Premium Content
Subscriber only
Australians suffering from a severe form of eczema will now have access to a life changing medicine through the Pharmaceutical Benefits Scheme.
Page MP Kevin Hogan said it would help support to patients and their families.
The medicine Dupixent (dupilumab) will be available to Australians over 12 years of age living with severe atopic dermatitis, also referred to as eczema, who are not adequately controlled on topical therapy.
Eczema Support Australia managing director, Melanie Funk, said it was "the best news ever".
"There will be tears of relief that this breakthrough medicine is now available for Australians with severe eczema, regardless of their ability to pay," she said.